PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN

Autor: Ikeda, S., Kudo, M., Izumi, N., Kaneko, S., Kobayashi, M., Azuma, M., Copher, R., Virabhak, S., Mitchell, D., Meier, G., Ishii, M.
Zdroj: In Value in Health October 2018 21 Supplement 3:S46-S46
Databáze: ScienceDirect